Adar Poonawalla has played a crucial role in the global fight against COVID-19 by leading the production of the Oxford-AstraZeneca vaccine, known as Covishield in India.
The vaccine was developed by the Jenner Institute at Oxford University and Serum Institute of India with support from the European and Developing Countries Clinical Trials Partnership (‘EDCTP’), the Wellcome Trust, and the European Investment Bank (‘EIB’).
"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive offers hope for a future free from annual outbreaks and epidemics in the African meningitis belt. It is a big moment as we, together, pave the way towards a healthier Africa, saving countless lives," Poonawala said.
Gavi, the vaccine alliance, to provide 18 million doses of malaria vaccine to African countries. Bharat Biotech and Serum Institute of India are going to be the manufacturers in the global effort.
Covovax vaccination course consists of two separate doses of 0.5 ml each. After receiving one dose of the vaccine, the second dose should be administered after 3 weeks.